Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery

Annals of Thoracic Surgery

Volumn 75, Issue 1, 2003, Pages 17-22

  Francis, John L ^a,b   Palmer III, George J ^a   Moroose, Rebecca ^a   Drexler, Alane ^a  

^a FLORIDA HOSPITAL   (United States)

^b FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; THROMBOCYTE FACTOR 4;

AGED; ANTIBODY PRODUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CATTLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART SURGERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SWINE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

ANIMALS; ANTIBODY FORMATION; CARDIAC SURGICAL PROCEDURES; CATTLE; CORONARY ARTERY BYPASS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HUMANS; PLATELET COUNT; PLATELET FACTOR 4; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SWINE; THROMBOCYTOPENIA;

EID: 0037236532     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04349-7     Document Type: Article

References (25)

1. Cartier R, Robitaille D. Thrombotic complications in beating heart operations. J Thorac Cardiovasc Surg 2001;121:920-2.
2. Fabris F, Luzzatto G, Stefani PM, Girolami B, Cella G, Girolami A. Heparin-induced thrombocytopenia. Haematologica 2000;85:72-81.
3. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001;344:1286-92.
4. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Amer J Med 1996;101:502-7.
5. Alving BM, Krishnamurti C. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis. Semin Thromb Hemost 1997;23:569-74.
6. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis, frequency, avoidance and management. Drug Saf 1997;17:325-41.
7. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81-8.
8. Warkentin TE. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transfus Med Rev 1996;10:249-58.
9. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin [see comments]. N Engl J Med 1995;332:1330-5.
10. Vun CM, Evans S, Chong BH. Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia. Thromb Res 1996;81:525-32.
11. Bell WR, Royall RM. Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med 1980;303:902-7.
12. Cipolle RJ, Rodvold KA, Seifert R, Clarens R, Ramirez-Lassepas M. Heparin-associated thrombocytopenia: a prospective evaluation of 211 patients. Ther Drug Monit 1983;5:205-11.
13. Green D, Martin GJ, Shoichet SH, DeBacker N, Bomalaski JS, Lind RN. Thrombocytopenia in a prospective, randomized, double-blind trial of bovine and porcine heparin. Am J Med Sci 1984;288:60-4.
14. Schmitt BP, Adelman B. Heparin-associated thrombocytopenia: a critical review and pooled analysis. Am J Med Sci 1993;305:208-15.
15. Trossaert M, Gaillard A, Commin PL, Amiral J, Vissac AM, Fressinaud E. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol 1998;101:653-5.
16. Pouplard C, May MA, Iochmann S, et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation 1999;99:2530-6.
17. Visentin GP, Malik M, Cyganiak KA, Aster RH. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platelet factor 4 complexes. J Lab Clin Med 1996;128:376-83.
18. Casati V, Gerli C, Franco A, et al. Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiol 2001;95:1103-9.
19. Konkle BA, Bauer TL, Arepally G, et al. Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery. Ann Thorac Surg 2001;71:1920-4.
20. Bauer TL, Arepally G, Konkle BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242-6.
21. Von Segesser LK, Mueller X, Marty B, Horisberger J, Corno A. Alternatives to unfractioned heparin for anticoagulation in cardiopulmonary bypass. Perfusion 2001;16:411-6.
22. Warkentin TE, Dunn GL, Cybulsky IJ. Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia. Ann Thorac Surg 2001;72:1730-2.
23. Nemergut C, Cheng JW. Use of direct thrombin inhibitors in acute coronary syndrome. Clin Ther 2000;22:937-48.
24. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001;135:502-6.
25. Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med 2002;136:210-5.